- TWD11.24bn
- TWD18.41bn
- TWD7.63bn
- 10
- 23
- 91
- 33
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 7,779 | 6,578 | 7,477 | 7,739 | 7,630 |
Cost of Revenue | |||||
Gross Profit | 539 | 877 | 1,187 | 1,319 | 1,196 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 10,117 | 7,068 | 7,771 | 8,021 | 8,011 |
Operating Profit | -2,338 | -490 | -294 | -282 | -381 |
Gain / Loss on Sale of Assets | |||||
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -2,470 | -730 | -3.98 | 20.5 | -146 |
Provision for Income Taxes | |||||
Net Income After Taxes | -2,571 | -802 | -126 | -68.1 | -379 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | -2,255 | -897 | -341 | -149 | -303 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Dilution Adjustment | |||||
Diluted Net Income | -2,255 | -897 | -341 | -149 | -303 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -1.96 | -1.24 | -0.52 | -0.209 | -0.443 |
Dividends per Share |